Compare
Amgen vs Vericel (AMGN vs VCEL)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Amgen (AMGN) returned +43.9% and Vericel (VCEL) +46.8%; so far this year the figures are +40.7% and +51.7%.
Amgen is the larger company by market value, about 89.3 times the size of Vericel.
On trailing earnings, AMGN trades at 26.7 times and VCEL at 85.3 times.
Revenue grew +8.2% at AMGN and +25.3% at VCEL over the last year.
AMGN yields 2.16%. VCEL pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| AMGN | VCEL | |
|---|---|---|
| Price | $460.42 | $54.62 |
| 1-day | +0.03% | +5.48% |
| YTD | +40.67% | +51.68% |
| 1 year | +43.94% | +46.83% |
| 3 years | +76.51% | +56.06% |
| Market cap | $249.1B | $2.8B |
| P/E | 26.7 | 85.3 |
| P/S | 6.40 | 8.60 |
| P/B | 17.35 | 7.26 |
| Revenue growth | +8.20% | +25.30% |
| EPS growth | +33.30% | +156.00% |
| Gross margin % | 70.9 | 74.5 |
| Net margin % | 24.1 | 10.3 |
| ROE % | 65.4 | 8.7 |
| Debt / equity | 3.76 | 0.03 |
| FCF yield % | 3.8 | 2.1 |
| Dividend yield % | 2.16 | — |
| Beta | 0.50 | 0.43 |
| RSI (14) | 60.5 | 78.4 |
| Technical rating |